Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Lactose API

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ritter's microbiome modulator fails lactose intolerance phase 3 
    Ritter's microbiome modulator fails lactose intolerance phase 3 

    13 Sep 2019

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ritter-s-microbiome-modulator-fails-lactose-intolerance-phase-3

    Nick Paul Taylor FIERCE BIOTECH
    13 Sep 2019
    Share Share
    Oral dosage forms containing nimodipine solid dispersion & hydrophilic carriers
    Oral dosage forms containing nimodipine solid dispersion & hydrophilic carriers

    08 Nov 2016

    // PHARMA EXCIPIENTS

    http://www.pharma-excipients.ch/2016/11/08/controlled-release-oral-dosage-forms-containing-nimodipine-solid-dispersion-and-hydrophilic-carriers/

    PHARMA EXCIPIENTS
    08 Nov 2016
    Share Share
    Excipients Market to Reach US$626.9 Million by 2023
    Excipients Market to Reach US$626.9 Million by 2023

    17 May 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/excipients-market-to-reach-us6269-million-by-2023---latin-america-industry-analysis-size-share-growth-trends-and-forecast-2015---2023-579805421.html

    PR NEWSWIRE
    17 May 2016
    Share Share
    Scaling up a high shear granulation process to gain granules suitable to formulate orally disintegrating tablets
    Scaling up a high shear granulation process to gain granules suitable to formulate orally disintegrating tablets

    21 Apr 2016

    // PHARMA-EXCIPIENTS

    http://www.pharma-excipients.ch/2016/04/21/scaling-up-a-high-shear-granulation-process-to-gain-granules-suitable-to-formulate-orally-disintegrating-tablets/

    PHARMA-EXCIPIENTS
    21 Apr 2016
    Share Share
    Custom-made solutions in Inhalation - DMV Lactose
    Custom-made solutions in Inhalation - DMV Lactose

    21 Mar 2016

    // PHARMA-EXCIPIENTS

    http://www.pharma-excipients.ch/2016/03/21/custom-made-solutions-in-inhalation-dmv-lactose/

    PHARMA-EXCIPIENTS
    21 Mar 2016
    Share Share
    A New Enhanced Sorbitol: Calcium Diphosphate Composite As A Direct Compression Excipient: A Comparative Study
    A New Enhanced Sorbitol: Calcium Diphosphate Composite As A Direct Compression Excipient: A Comparative Study

    29 Feb 2016

    // PHARMA-EXCIPIENTS

    http://www.pharma-excipients.ch/2016/02/27/a-new-enhanced-sorbitol-calcium-diphosphate-composite-as-a-direct-compression-excipient-a-comparative-study/

    PHARMA-EXCIPIENTS
    29 Feb 2016
    Share Share